Stephen P Macmillan Hologic Inc (HOLX) insider trading activity

Stephen P Macmillan is Chairman, President and CEO of HOLOGIC INC. Currently has a direct ownership of 1.23 Million shares of HOLX, which is worth approximately $89.7 Million. The most recent transaction as insider was on Nov 14, 2024, when has been sold 6,860 shares (Common Stock) at a price of $77.54 per share, resulting in proceeds of $531,924. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.23M

6.63% 3M change

0.39% 12M change

Total Value Held $89.7 Million

STEPHEN P MACMILLAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2024	SELL Payment of exercise price or tax liability	$531,924 $77.54 p/Share	6,860 Reduced 0.55%	1,234,278 Common Stock
Nov 11 2024	BUY Grant, award, or other acquisition	-	39,677 Added 3.1%	1,241,138 Common Stock
Nov 08 2024	SELL Payment of exercise price or tax liability	$5,390,885 $78.76 p/Share	68,447 Reduced 5.39%	1,201,461 Common Stock
Nov 07 2024	SELL Payment of exercise price or tax liability	$492,708 $79.29 p/Share	6,214 Reduced 0.49%	1,269,908 Common Stock
Nov 05 2024	BUY Grant, award, or other acquisition	-	118,560 Added 8.5%	1,276,122 Common Stock
Jul 30 2024	SELL Open market or private sale	$3,586,976 $81.45 p/Share	44,039 Reduced 3.67%	1,157,562 Common Stock
Jul 30 2024	BUY Exercise of conversion of derivative security	$1,154,262 $26.21 p/Share	44,039 Added 3.54%	1,201,601 Common Stock
Jul 17 2024	SELL Open market or private sale	$294,237 $80.13 p/Share	3,672 Reduced 0.32%	1,157,562 Common Stock
Jul 17 2024	BUY Exercise of conversion of derivative security	$96,243 $26.21 p/Share	3,672 Added 0.32%	1,161,234 Common Stock
May 23 2024	SELL Bona fide gift	-	57,875 Reduced 4.76%	1,157,213 Common Stock
Apr 22 2024	SELL Bona fide gift	-	12,000 Reduced 0.98%	1,215,088 Common Stock
Apr 19 2024	SELL Bona fide gift	-	12,000 Reduced 0.97%	1,227,088 Common Stock
Nov 29 2023	SELL Open market or private sale	$3,359,331 $70.41 p/Share	47,711 Reduced 3.71%	1,239,088 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	$1,250,505 $26.21 p/Share	47,711 Added 3.58%	1,286,799 Common Stock
Nov 14 2023	BUY Grant, award, or other acquisition	-	40,832 Added 3.19%	1,239,088 Common Stock
Nov 09 2023	SELL Payment of exercise price or tax liability	$4,422,499 $67.2 p/Share	65,811 Reduced 5.21%	1,198,256 Common Stock
Nov 08 2023	SELL Payment of exercise price or tax liability	$371,525 $68.27 p/Share	5,442 Reduced 0.43%	1,264,067 Common Stock
Nov 07 2023	SELL Payment of exercise price or tax liability	$271,702 $68.37 p/Share	3,974 Reduced 0.31%	1,269,509 Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	-	24,133 Added 1.86%	1,273,483 Common Stock
Aug 30 2023	SELL Bona fide gift	-	1,064,954 Reduced 46.02%	1,249,350 Common Stock
Nov 30 2022	SELL Open market or private sale	$2,536,620 $75.72 p/Share	33,500 Reduced 1.43%	2,313,970 Common Stock
Nov 11 2022	SELL Open market or private sale	$10,481,313 $75.72 p/Share	138,422 Reduced 5.36%	2,443,825 Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$7,316,235 $75.93 p/Share	96,355 Reduced 3.94%	2,347,470 Common Stock
Nov 11 2022	BUY Exercise of conversion of derivative security	$2,501,010 $26.21 p/Share	95,422 Added 3.62%	2,539,247 Common Stock
Nov 09 2022	SELL Payment of exercise price or tax liability	$416,507 $72.11 p/Share	5,776 Reduced 0.23%	2,486,825 Common Stock

Also insider at

BSX

BOSTON SCIENTIFIC CORP Healthcare

Director

ILMN

ILLUMINA, INC. Healthcare

Director

SPM